[HTML][HTML] Triple-negative breast cancer: a review of conventional and advanced therapeutic strategies
Triple-negative breast cancer (TNBC) cells are deficient in estrogen, progesterone and
ERBB2 receptor expression, presenting a particularly challenging therapeutic target due to …
ERBB2 receptor expression, presenting a particularly challenging therapeutic target due to …
[HTML][HTML] Metastatic breast cancer: the potential of miRNA for diagnosis and treatment monitoring
Breast cancer affects approximately 12% women worldwide and results in 14% of all cancer-
related fatalities. Breast cancer is commonly categorized into one of four main subtypes …
related fatalities. Breast cancer is commonly categorized into one of four main subtypes …
[HTML][HTML] MiRNA and LncRNA as potential biomarkers in triple-negative breast cancer: a review
SR Volovat, C Volovat, I Hordila, DA Hordila… - Frontiers in …, 2020 - frontiersin.org
Noncoding RNAs (ncRNAs) include a diverse range of RNA species, including microRNAs
(miRNAs) and long noncoding RNAs (lncRNAs). MiRNAs, ncRNAs of approximately 19–25 …
(miRNAs) and long noncoding RNAs (lncRNAs). MiRNAs, ncRNAs of approximately 19–25 …
[HTML][HTML] miR-134 in extracellular vesicles reduces triple-negative breast cancer aggression and increases drug sensitivity
Exosomes (EVs) have relevance in cell-to-cell communication carrying pro-tumorigenic
factors that participate in oncogenesis and drug resistance and are proposed to have …
factors that participate in oncogenesis and drug resistance and are proposed to have …
[HTML][HTML] Triple negative breast cancer: the kiss of death
AA Jitariu, AM Cîmpean, D Ribatti, M Raica - Oncotarget, 2017 - ncbi.nlm.nih.gov
One of the most controversial women malignancies, triple negative breast cancers (TNBCs)
are critically overviewed here, being focused on data useful in clinical practice or to improve …
are critically overviewed here, being focused on data useful in clinical practice or to improve …
[HTML][HTML] MicroRNAs involved in carcinogenesis, prognosis, therapeutic resistance, and applications in human triple-negative breast cancer
L Ding, H Gu, X Xiong, H Ao, J Cao, W Lin, M Yu, J Lin… - Cells, 2019 - mdpi.com
Triple-negative breast cancer (TNBC) is the most aggressive, prevalent, and distinct subtype
of breast cancer characterized by high recurrence rates and poor clinical prognosis, devoid …
of breast cancer characterized by high recurrence rates and poor clinical prognosis, devoid …
Protective role of miR-155 in breast cancer through RAD51 targeting impairs homologous recombination after irradiation
Cell survival after DNA damage relies on DNA repair, the abrogation of which causes
genomic instability and development of cancer. However, defective DNA repair in cancer …
genomic instability and development of cancer. However, defective DNA repair in cancer …
[HTML][HTML] Circulating cell-free miRNAs as biomarker for triple-negative breast cancer
VY Shin, JM Siu, I Cheuk, EKO Ng, A Kwong - British journal of cancer, 2015 - nature.com
Background: Triple-negative breast cancer (TNBC) accounts for 15–20% of all breast cancer
in women globally. This subtype often has early and high recurrence rates resulting in poor …
in women globally. This subtype often has early and high recurrence rates resulting in poor …
[HTML][HTML] A nineteen gene-based risk score classifier predicts prognosis of colorectal cancer patients
Colorectal cancer (CRC) patients frequently experience disease recurrence and distant
metastasis. This study aimed to identify prognostic indicators, including individual responses …
metastasis. This study aimed to identify prognostic indicators, including individual responses …
Role of androgen and microRNA in triple-negative breast cancer
Breast cancer (BC) is the most frequent type of malignancy affecting females worldwide.
Molecular–based studies resulted in an identification of at least four subtypes of breast …
Molecular–based studies resulted in an identification of at least four subtypes of breast …